Login to Your Account



Search

Search results

Pharma: Clinic roundup

Boehringer Ingelheim GmbH , of Ingelheim, Germany, reported results from the phase III STARTVerso 4 trial in patients co-infected with hepatitis C virus (HCV) and HIV, showing that HCV cure 12 weeks (SVR12) after the conclusion of treatment was ach ...

BioWorld Today - Staff - 2014-03-07 01:00 - 0 comments - 0 attachments

Clinic roundup

Ico Therapeutics Inc. , of Vancouver, British Columbia, disclosed the final, eight-month patient visit in the phase II iDEAL study. The investigator-sponsored study is evaluating the efficacy and safety of ICO-007 after repeated injections in pat ...

BioWorld Today - Staff - 2014-03-06 01:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Roche AG , of Basel, Switzerland, presented new data from the LUTE/VERSE phase IIb studies investigating lebrikizumab in patients with severe uncontrolled asthma. The data showed that asthma attacks were reduced by 60 percent in lebrikizumab-trea ...

BioWorld Today - Staff - 2014-03-06 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Janssen Pharmaceutica NV , of Beerse, Belgium, part of Johnson & Johnson, reported results from the PROSIPAL (Prevention of Relapse With Oral Antipsychotics Versus Injectable Paliperidone Palmitate) study at the European Congress of Psychiatry ...

BioWorld Today - Staff - 2014-03-05 01:00 - 0 comments - 0 attachments

Clinic roundup

Boston Therapeutics Inc. , of Manchester, N.H., said it received institutional review board approval to start a phase II study of BTI-320 (formerly PAZ320), a nonsystemic chewable complex carbohydrate-based compound, in the U.S. (BioWorld-To ...

BioWorld Today - Staff - 2014-03-05 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Boehringer Ingelheim Corp. , of Ridgefield, Conn., part of Boehringer Ingelheim GmbH, presented data from phase III studies of tiotropium delivered via the Respimat inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of ...

BioWorld Today - Staff - 2014-03-04 01:00 - 0 comments - 0 attachments

Clinic roundup

Chimerix Inc. , of Durham, N.C., released favorable data from presentations at the 2014 BMT Tandem Meetings related to its investigational antiviral with broad-spectrum activity, brincidofovir (CMX001). (BioWorld-Today-2014-03-03) ...

BioWorld Today - Staff - 2014-03-03 01:00 - 0 comments - 0 attachments

Clinic roundup

Immune Design Corp. , of Seattle, reported the first patient has been treated in a phase I trial of ID-G305, a cancer immunotherapy. (BioWorld-Today-2014-02-28) ...

BioWorld Today - Staff - 2014-02-28 01:00 - 0 comments - 0 attachments

Pharma: Clinic roundup

Eisai Inc. , of Woodcliff Lake, N.J., said it started a phase III trial to compare the efficacy, safety and tolerability of eribulin mesylate to standard weekly paclitaxel as first- or second-line treatment for HER2-negative locally recurrent or meta ...

BioWorld Today - Staff - 2014-02-28 01:00 - 0 comments - 0 attachments

Clinic roundup

Altheus Therapeutics Inc. , of Oklahoma City, said it completed dosing in ZA201, a double-blind, active-controlled phase II trial evaluating the efficacy and safety of Zoenasa rectal gel vs. mesalamine enema in 120 patients with left-sided ulcerative ...

BioWorld Today - Staff - 2014-02-27 01:00 - 0 comments - 0 attachments